Impaired biliary lipid secretion in obese Zucker rats: leptin promotes hepatic cholesterol clearance.
Human obesity is associated with elevated plasma leptin levels. Obesity is also an important risk factor for cholesterol gallstones, which form as a result of cholesterol hypersecretion into bile. Because leptin levels are correlated with gallstone prevalence, we explored the effects of acute leptin administration on biliary cholesterol secretion using lean (FA/-) and obese (fa/fa) Zucker rats. Zucker (fa/fa) rats become obese and hyperleptinemic due to homozygosity for a missense mutation in the leptin receptor, which diminishes but does not completely eliminate responsiveness to leptin. Rats were infused intravenously for 12 h with saline or pharmacological doses of recombinant murine leptin (5 microg x kg(-1) x min(-1)) sufficient to elevate plasma leptin concentrations to 500 ng/ml compared with basal levels of 3 and 70 ng/ml in lean and obese rats, respectively. Obesity was associated with a marked impairment in biliary cholesterol secretion. In biles of obese compared with lean rats, bile salt hydrophobicity was decreased whereas phosphatidylcholine hydrophobicity was increased. High-dose leptin partially normalized cholesterol secretion in obese rats without altering lipid compositions, implying that both chronic effects of obesity and relative resistance to leptin contributed to impaired biliary cholesterol elimination. In lean rats, acute leptin administration increased biliary cholesterol secretion rates. Without affecting hepatic cholesterol contents, leptin downregulated hepatic activity of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase, upregulated activities of both sterol 27-hydroxylase and cholesterol 7alpha-hydroxylase, and lowered plasma very low-density lipoprotein cholesterol concentrations. Increased biliary cholesterol secretion in the setting of decreased cholesterol biosynthesis and increased catabolism to bile salts suggests that leptin promotes elimination of plasma cholesterol.
VanPatten
S
S
Department of Biochemistry, Marion Bessin Liver Research Center, Albert Einstein College of Medicine, Bronx, New York 10461, USA.
Ranginani
N
N
Shefer
S
S
Nguyen
L B
LB
Rossetti
L
L
Cohen
D E
DE
D000818:Animals; D001647:Bile Acids and Salts / Q000737:chemistry; D001659:Biliary Tract / Q000378:metabolism*; D002784:Cholesterol / Q000378:metabolism*; D015243:Cholesterol, VLDL / Q000097:blood; D020738:Leptin / Q000494:pharmacology*; D008099:Liver / Q000378:metabolism*; D008297:Male; D008954:Models, Biological; D009765:Obesity / Q000378:metabolism*; D010713:Phosphatidylcholines / Q000378:metabolism; D010743:Phospholipids / Q000378:metabolism*; D051381:Rats; D011924:Rats, Zucker
D001647:Bile Acids and Salts; D015243:Cholesterol, VLDL; D020738:Leptin; D010713:Phosphatidylcholines; D010743:Phospholipids; D002784:Cholesterol